Adverse Effects

Home • AltMed Home • Search • Feedback

 

Background
Preterm Labor
Cardiovascular Health
Adverse Effects
Dietary Sources
Recipes
Conclusions
Resources
Additional Links

 

Adverse Effects of Omega-3 Fatty Acid Intake


There are few recognized adverse effects of omega-3 fatty acid administration.  When present, they are related almost exclusively to the administration of supplements in capsule or pill form. 

Subjects reported a higher incidence of both belching and unpleasant taste if they were taking fish oil capsules rather than olive oil capsules, or some other placebo.  This adverse effect seems entirely limited to those using supplements, such as the fish oil capsules, to ingest omega-3 FAs.  People who increase their omega-3 FA intake purely by dietary means (eating more fish, flaxseed, flaxseed oil, etc.) have experienced no adverse effects.

Omega-3 fatty acids exert a dose-related effect on bleeding time; however, there are no documented cases of abnormal bleeding as a result of fish oil supplementation, even at high dosages and in combination with other anticoagulant medications.  However, Omega-3 fatty acids should be used cautiously by people who bruise easily, have a bleeding disorder, or take blood-thinning medications.  Intake should be limited to less than three grams per day (less than 3 servings of fish per day).

High dosages of fish oil may increase LDL cholesterol levels, but the clinical relevance of this finding remains unclear.

Although past studies have found that regular consumption of fish may reduce the risk of macular degeneration, a recent study found that diets rich in ALA may actually increase the risk of this disease.  Until more data is obtained, it is best for people with macular degeneration to obtain omega-3 fatty acids from sources of EPA and DHA, rather than ALA.

No adverse effects on pregnancy have been shown in humans.  Some studies in animals have reported an increase in the rates of prolonged and difficult labors and an increase in blood loss during labor.  These results were shown only with much higher doses of omega-3 FA than have ever been used in human studies.  These effects have not been shown in human studies. 

It is important to be aware of the two types of fish oil supplement — those made from the liver of the fish and those made from the body of the fish. Supplements made from the liver of the fish, such as cod liver oil, contain the retinol form of vitamin A and need to be either avoided altogether or strictly limited in pregnancy so that your daily intake does not exceed 3,300 micrograms (mcg). On the other hand, fish oils not derived from fish livers contain lots of DHA (docosahexaenoic acid), which is essential for your baby's developing eyes and brain.

Significant amounts of methylmercury, polychlorinated biphenyls, dioxins, and other environmental contaminants may be concentrated in certain species of fish, such as shark, swordfish, king mackerel, and tilefish (also known as golden bass or golden snapper).   In March 2004, the U.S. Food and Drug Administration (FDA) and the Environmental Protection Agency issued a new statement advising women who may become pregnant, women who are pregnant, breastfeeding mothers, and young children to avoid eating some types of fish and to eat fish and shellfish that are lower in mercury. These recommendations can be found by visiting: http://www.cfsan.fda.gov/~dms/admehg3.html.  High-quality fish oil supplements usually do not contain these contaminants.

Although it has not been shown to be statistically significant in human studies, there is a theoretical risk of increasing the rate of post-term delivery when increasing omega-3 FA intake throughout pregnancy.  If the use of omega-3 FAs during an entire pregnancy or during the third trimester results in longer duration of pregnancy, then it makes intuitive sense that pregnancies that would have culminated with labor at 40 weeks gestation without the increase in omega-3 FA might be prolonged as well, resulting in an increase in the rate of post-term (>42 weeks gestation) deliveries.  Combating this theoretical risk would be easily accomplished by having women stop their method of omega-3 supplementation around 38 weeks gestation.  As stated previously, though, this has only been shown as a trend in recent research, not as a statistically significant adverse effect.  The risk is theoretical.

Because of the potential for side effects and interactions with medications, dietary supplements should be taken only under the supervision of a knowledgeable healthcare provider.